| Authors: |
Lagatie O; Johnson & Johnson Global Public Health Research & Development, Beerse, Belgium., Lauwers D; Johnson & Johnson Global Public Health Research & Development, Beerse, Belgium., Singh H; Johnson & Johnson Global Public Health Research & Development, Beerse, Belgium., Vanroye F; Institute of Tropical Medicine, Antwerp, Belgium., Stieh DJ; Janssen Vaccines and Prevention B.V., Leiden, The Netherlands., Vingerhoets J; Janssen Research & Development, Beerse, Belgium., Lavreys L; Janssen Vaccines and Prevention B.V., Leiden, The Netherlands., Oriol-Mathieu V; Janssen Vaccines and Prevention B.V., Leiden, The Netherlands., Colón W; Johnson & Johnson Global Public Health Research & Development, Beerse, Belgium., Verhofstede C; Ghent University, Ghent, Belgium., Vercauteren K; Institute of Tropical Medicine, Antwerp, Belgium., Van den Bossche D; Institute of Tropical Medicine, Antwerp, Belgium., Pau MG; Janssen Vaccines and Prevention B.V., Leiden, The Netherlands. |